Investigating the Transepithelial Transport and Enzymatic Stability of Lactononadecapeptide (NIP­PLT­QTP­VVV­PPF­LQ­PE), a 19-Amino Acid Casein-Derived Peptide in Caco‑2 Cells

Lactononadecapeptide (LNDP; NIP­PLT­QTP­VVV­PPF­LQ­PE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function. This study aimed to explore the transepithelial transport and stability of LNDP. Results showed that LNDP retained over 90% stability afte...

Full description

Saved in:
Bibliographic Details
Published inJournal of Agricultural and Food Chemistry Vol. 72; no. 22; pp. 12719 - 12724
Main Authors Nakatani, Eriko, Sasai, Masaki, Miyazaki, Hidetoshi, Tanaka, Shimako, Hirota, Tatsuhiko, Okura, Takashi
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 05.06.2024
American Chemical Society (ACS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Lactononadecapeptide (LNDP; NIP­PLT­QTP­VVV­PPF­LQ­PE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function. This study aimed to explore the transepithelial transport and stability of LNDP. Results showed that LNDP retained over 90% stability after 2 h of treatment with gastrointestinal enzymes. The stability of LNDP on Caco-2 cell monolayers ranged from 93.4% ± 0.9% to 101.1% ± 1.2% over a period of 15–60 min, with no significant differences at each time point. The permeability of LNDP across an artificial lipid membrane was very low with the effective permeability of 3.6 × 10–11 cm/s. The Caco-2 assay demonstrated that LNDP could traverse the intestinal epithelium, with an apparent permeability of 1.22 × 10–6 cm/s. Its transport was significantly inhibited to 67.9% ± 5.0% of the control by Gly-Pro, a competitor of peptide transporter 1 (PEPT1). Furthermore, PEPT1 knockdown using siRNA significantly inhibited LNDP transport by 77.6% ± 1.9% in Caco-2 cell monolayers. The LNDP uptake in PEPT1-expressing HEK293 cells was significantly higher (54.5% ± 14.6%) than that in mock cells. These findings suggest that PEPT1 plays a crucial role in LNDP transport, and LNDP exhibits good resistance to gastrointestinal enzymes.
AbstractList Lactononadecapeptide (LNDP; NIP­PLT­QTP­VVV­PPF­LQ­PE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function. This study aimed to explore the transepithelial transport and stability of LNDP. Results showed that LNDP retained over 90% stability after 2 h of treatment with gastrointestinal enzymes. The stability of LNDP on Caco-2 cell monolayers ranged from 93.4% ± 0.9% to 101.1% ± 1.2% over a period of 15–60 min, with no significant differences at each time point. The permeability of LNDP across an artificial lipid membrane was very low with the effective permeability of 3.6 × 10–¹¹ cm/s. The Caco-2 assay demonstrated that LNDP could traverse the intestinal epithelium, with an apparent permeability of 1.22 × 10–⁶ cm/s. Its transport was significantly inhibited to 67.9% ± 5.0% of the control by Gly-Pro, a competitor of peptide transporter 1 (PEPT1). Furthermore, PEPT1 knockdown using siRNA significantly inhibited LNDP transport by 77.6% ± 1.9% in Caco-2 cell monolayers. The LNDP uptake in PEPT1-expressing HEK293 cells was significantly higher (54.5% ± 14.6%) than that in mock cells. These findings suggest that PEPT1 plays a crucial role in LNDP transport, and LNDP exhibits good resistance to gastrointestinal enzymes.
Lactononadecapeptide (LNDP; NIPPLTQTPVVVPPFLQPE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function. This study aimed to explore the transepithelial transport and stability of LNDP. Results showed that LNDP retained over 90% stability after 2 h of treatment with gastrointestinal enzymes. The stability of LNDP on Caco-2 cell monolayers ranged from 93.4% ± 0.9% to 101.1% ± 1.2% over a period of 15–60 min, with no significant differences at each time point. The permeability of LNDP across an artificial lipid membrane was very low with the effective permeability of 3.6 × 10 –11 cm/s. The Caco-2 assay demonstrated that LNDP could traverse the intestinal epithelium, with an apparent permeability of 1.22 × 10 –6 cm/s. Its transport was significantly inhibited to 67.9% ± 5.0% of the control by Gly-Pro, a competitor of peptide transporter 1 (PEPT1). Furthermore, PEPT1 knockdown using siRNA significantly inhibited LNDP transport by 77.6% ± 1.9% in Caco-2 cell monolayers. The LNDP uptake in PEPT1-expressing HEK293 cells was significantly higher (54.5% ± 14.6%) than that in mock cells. These findings suggest that PEPT1 plays a crucial role in LNDP transport, and LNDP exhibits good resistance to gastrointestinal enzymes.
Lactononadecapeptide (LNDP; NIPPLTQTPVVVPPFLQPE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function. This study aimed to explore the transepithelial transport and stability of LNDP. Results showed that LNDP retained over 90% stability after 2 h of treatment with gastrointestinal enzymes. The stability of LNDP on Caco-2 cell monolayers ranged from 93.4% ± 0.9% to 101.1% ± 1.2% over a period of 15-60 min, with no significant differences at each time point. The permeability of LNDP across an artificial lipid membrane was very low with the effective permeability of 3.6 × 10-11 cm/s. The Caco-2 assay demonstrated that LNDP could traverse the intestinal epithelium, with an apparent permeability of 1.22 × 10-6 cm/s. Its transport was significantly inhibited to 67.9% ± 5.0% of the control by Gly-Pro, a competitor of peptide transporter 1 (PEPT1). Furthermore, PEPT1 knockdown using siRNA significantly inhibited LNDP transport by 77.6% ± 1.9% in Caco-2 cell monolayers. The LNDP uptake in PEPT1-expressing HEK293 cells was significantly higher (54.5% ± 14.6%) than that in mock cells. These findings suggest that PEPT1 plays a crucial role in LNDP transport, and LNDP exhibits good resistance to gastrointestinal enzymes.Lactononadecapeptide (LNDP; NIPPLTQTPVVVPPFLQPE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function. This study aimed to explore the transepithelial transport and stability of LNDP. Results showed that LNDP retained over 90% stability after 2 h of treatment with gastrointestinal enzymes. The stability of LNDP on Caco-2 cell monolayers ranged from 93.4% ± 0.9% to 101.1% ± 1.2% over a period of 15-60 min, with no significant differences at each time point. The permeability of LNDP across an artificial lipid membrane was very low with the effective permeability of 3.6 × 10-11 cm/s. The Caco-2 assay demonstrated that LNDP could traverse the intestinal epithelium, with an apparent permeability of 1.22 × 10-6 cm/s. Its transport was significantly inhibited to 67.9% ± 5.0% of the control by Gly-Pro, a competitor of peptide transporter 1 (PEPT1). Furthermore, PEPT1 knockdown using siRNA significantly inhibited LNDP transport by 77.6% ± 1.9% in Caco-2 cell monolayers. The LNDP uptake in PEPT1-expressing HEK293 cells was significantly higher (54.5% ± 14.6%) than that in mock cells. These findings suggest that PEPT1 plays a crucial role in LNDP transport, and LNDP exhibits good resistance to gastrointestinal enzymes.
Lactononadecapeptide (LNDP; NIPPLTQTPVVVPPFLQPE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function. This study aimed to explore the transepithelial transport and stability of LNDP. Results showed that LNDP retained over 90% stability after 2 h of treatment with gastrointestinal enzymes. The stability of LNDP on Caco-2 cell monolayers ranged from 93.4% ± 0.9% to 101.1% ± 1.2% over a period of 15-60 min, with no significant differences at each time point. The permeability of LNDP across an artificial lipid membrane was very low with the effective permeability of 3.6 × 10 cm/s. The Caco-2 assay demonstrated that LNDP could traverse the intestinal epithelium, with an apparent permeability of 1.22 × 10 cm/s. Its transport was significantly inhibited to 67.9% ± 5.0% of the control by Gly-Pro, a competitor of peptide transporter 1 (PEPT1). Furthermore, PEPT1 knockdown using siRNA significantly inhibited LNDP transport by 77.6% ± 1.9% in Caco-2 cell monolayers. The LNDP uptake in PEPT1-expressing HEK293 cells was significantly higher (54.5% ± 14.6%) than that in mock cells. These findings suggest that PEPT1 plays a crucial role in LNDP transport, and LNDP exhibits good resistance to gastrointestinal enzymes.
Lactononadecapeptide (LNDP; NIP­PLT­QTP­VVV­PPF­LQ­PE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function. This study aimed to explore the transepithelial transport and stability of LNDP. Results showed that LNDP retained over 90% stability after 2 h of treatment with gastrointestinal enzymes. The stability of LNDP on Caco-2 cell monolayers ranged from 93.4% ± 0.9% to 101.1% ± 1.2% over a period of 15–60 min, with no significant differences at each time point. The permeability of LNDP across an artificial lipid membrane was very low with the effective permeability of 3.6 × 10–11 cm/s. The Caco-2 assay demonstrated that LNDP could traverse the intestinal epithelium, with an apparent permeability of 1.22 × 10–6 cm/s. Its transport was significantly inhibited to 67.9% ± 5.0% of the control by Gly-Pro, a competitor of peptide transporter 1 (PEPT1). Furthermore, PEPT1 knockdown using siRNA significantly inhibited LNDP transport by 77.6% ± 1.9% in Caco-2 cell monolayers. The LNDP uptake in PEPT1-expressing HEK293 cells was significantly higher (54.5% ± 14.6%) than that in mock cells. These findings suggest that PEPT1 plays a crucial role in LNDP transport, and LNDP exhibits good resistance to gastrointestinal enzymes.
Author Sasai, Masaki
Okura, Takashi
Hirota, Tatsuhiko
Nakatani, Eriko
Tanaka, Shimako
Miyazaki, Hidetoshi
AuthorAffiliation Asahi Quality and Innovations, Ltd
Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences
Core Technology Laboratories
AuthorAffiliation_xml – name: Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences
– name: Core Technology Laboratories
– name: Asahi Quality and Innovations, Ltd
Author_xml – sequence: 1
  givenname: Eriko
  surname: Nakatani
  fullname: Nakatani, Eriko
  email: erikon@pharm.teikyo-u.ac.jp
  organization: Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences
– sequence: 2
  givenname: Masaki
  orcidid: 0009-0001-8095-5450
  surname: Sasai
  fullname: Sasai, Masaki
  organization: Asahi Quality and Innovations, Ltd
– sequence: 3
  givenname: Hidetoshi
  surname: Miyazaki
  fullname: Miyazaki, Hidetoshi
  organization: Asahi Quality and Innovations, Ltd
– sequence: 4
  givenname: Shimako
  surname: Tanaka
  fullname: Tanaka, Shimako
  organization: Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences
– sequence: 5
  givenname: Tatsuhiko
  surname: Hirota
  fullname: Hirota, Tatsuhiko
  organization: Asahi Quality and Innovations, Ltd
– sequence: 6
  givenname: Takashi
  surname: Okura
  fullname: Okura, Takashi
  organization: Laboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences
BackLink https://cir.nii.ac.jp/crid/1873399491341085952$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/38789103$$D View this record in MEDLINE/PubMed
BookMark eNqFUsFuEzEQtVARTQt3TsgHDkXqBnu96_WeqiikECmCVIRcLa_tTV1t7GXtRAonfoEPyZl7PoUvwSGhAiTgYs9o3nue8bwzcGKd1QA8xaiPUYpfCun7d6KW_UwiVBbZA9DDeYqSHGN2AnooYhKWU3wKzry_QwixvECPwClhBSsxIj3wdWzX2gezEMHYBQy3Gs46Yb1uTYwbI5pD3rouQGEVHNlPm2UES_g-iMo0Jmygq-FEyOBid0JpKVrdBqM0vHg7nu6208lst72ZxWg-n8d0er3bTm5iMHpxCQXEZTJYGuvgQBoFh8JrY5NXujNrreD0qGRsrEj37fOXFA510_jH4GEtGq-fHO9z8OF6NBu-SSbvXo-Hg0kiKKIhyUkqZVrVVYVUTqs4tURpqVRRlZJSwtJKU411JaTKmMqyHCnMKpGnuC4zShk5B1cH3XZVLbWS2oZONLztzFJ0G-6E4b9XrLnlC7fmGOO8iM9HhYujQuc-ruJf86XxMs4grHYrzwnOCcWxlez_UEQRKQhmKEKf_drXfUM_NxsB6ACQnfO-0_U9BCO-Nw-P5uF78_CjeSKF_kGRJsRVu_1kpvkX8fmBaI2JnP2JWUFIWWYlJhmOtivz_U9cHmA_BNyqs3Fzf1f9DutB6wg
CitedBy_id crossref_primary_10_1016_j_lwt_2024_117081
crossref_primary_10_1016_j_foodchem_2025_142935
crossref_primary_10_1016_j_foodres_2025_116065
Cites_doi 10.1017/S0954422416000032
10.1021/acs.jcim.1c00380
10.1002/jps.20075
10.1016/0006-291X(91)91647-U
10.3390/molecules24152843
10.1002/psc.870
10.1016/j.bbrc.2018.06.118
10.1016/j.coph.2013.08.004
10.1021/pr0705035
10.1002/mnfr.200700503
10.1021/jf703640p
10.1093/bbb/zbaa117
10.1038/368563a0
10.1016/j.ajps.2018.05.008
10.1021/acs.jafc.7b02176
10.1021/acs.jafc.3c04940
10.3390/molecules28031151
10.1016/0016-5085(89)90897-4
10.1007/s11095-005-6156-9
10.1016/0005-2744(74)90053-9
10.1152/ajpgi.00136.2002
10.1074/jbc.273.7.3861
10.1179/1476830514Y.0000000122
10.1016/j.peptides.2022.170843
10.1016/j.foodchem.2015.05.121
10.1083/jcb.102.6.2125
10.1002/psc.371
10.1074/jbc.270.47.28425
10.1271/bbb.66.378
10.1039/b301507f
10.1080/09637486.2017.1324564
10.3168/jds.S0022-0302(96)76585-2
10.1021/acs.jafc.1c08191
10.1002/mnfr.200900443
10.3168/jds.S0022-0302(95)76745-5
10.1021/jf405639w
10.3390/pharmaceutics15102517
10.3168/jds.S0022-0302(04)73453-0
10.1080/09637486.2017.1365824
10.1002/(SICI)1521-3803(19990601)43:3<154::AID-FOOD154>3.0.CO;2-A
10.1002/0471140864.ps2103s25
10.1096/fj.201900621R
10.1016/j.jff.2017.06.001
10.1042/bj2840595
10.1016/j.neurobiolaging.2018.07.016
10.1021/acs.jafc.5b01824
ContentType Journal Article
Copyright 2024 The Authors. Published by American Chemical Society
2024 The Authors. Published by American Chemical Society 2024 The Authors
Copyright_xml – notice: 2024 The Authors. Published by American Chemical Society
– notice: 2024 The Authors. Published by American Chemical Society 2024 The Authors
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOI 10.1021/acs.jafc.4c00974
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Agriculture
EISSN 1520-5118
EndPage 12724
ExternalDocumentID PMC11157532
38789103
10_1021_acs_jafc_4c00974
c655388378
Genre Journal Article
GroupedDBID ---
-~X
.K2
4.4
55A
5GY
5VS
7~N
85S
AABXI
AAHBH
ABFRP
ABJNI
ABMVS
ABQRX
ABUCX
ACGFO
ACGFS
ACJ
ACS
ADHLV
AEESW
AENEX
AFEFF
AGXLV
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
CS3
CUPRZ
DU5
EBS
ED~
F5P
GGK
GNL
GX1
IH9
JG~
LG6
P2P
ROL
TWZ
UI2
VF5
VG9
W1F
WH7
ABBLG
ABLBI
RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-a606t-532cc2bfbb0d56b789c029dd7b9c66382be6e1ebacd48d4450d18ba521f946683
IEDL.DBID ACS
ISSN 0021-8561
1520-5118
IngestDate Thu Aug 21 18:33:44 EDT 2025
Fri Jul 11 15:47:54 EDT 2025
Thu Jul 10 18:26:53 EDT 2025
Mon Jul 21 05:59:17 EDT 2025
Tue Jul 01 01:40:39 EDT 2025
Thu Apr 24 23:07:05 EDT 2025
Thu Jun 26 21:19:12 EDT 2025
Tue Jun 25 16:50:43 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 22
Keywords lactononadecapeptide (LNDP)
intestinal transport
peptide
Caco-2 cells
beta-casein
peptide transporter 1 (PEPT1)
Language English
License https://creativecommons.org/licenses/by-nc-nd/4.0
Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a606t-532cc2bfbb0d56b789c029dd7b9c66382be6e1ebacd48d4450d18ba521f946683
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0009-0001-8095-5450
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC11157532
PMID 38789103
PQID 3060373180
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11157532
proquest_miscellaneous_3153613824
proquest_miscellaneous_3060373180
pubmed_primary_38789103
crossref_primary_10_1021_acs_jafc_4c00974
crossref_citationtrail_10_1021_acs_jafc_4c00974
nii_cinii_1873399491341085952
acs_journals_10_1021_acs_jafc_4c00974
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-06-05
PublicationDateYYYYMMDD 2024-06-05
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-06-05
  day: 05
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of Agricultural and Food Chemistry
PublicationTitleAlternate J. Agric. Food Chem
PublicationYear 2024
Publisher American Chemical Society
American Chemical Society (ACS)
Publisher_xml – name: American Chemical Society
– name: American Chemical Society (ACS)
References ref9/cit9
ref45/cit45
ref3/cit3
ref27/cit27
ref16/cit16
ref8/cit8
ref31/cit31
ref2/cit2
ref34/cit34
ref37/cit37
ref20/cit20
ref48/cit48
Nakamura F. (ref26/cit26) 2018; 95
ref17/cit17
ref10/cit10
ref35/cit35
ref19/cit19
ref21/cit21
ref42/cit42
ref46/cit46
ref49/cit49
ref13/cit13
Nakamura F. (ref23/cit23) 2017; 45
ref24/cit24
ref38/cit38
ref6/cit6
ref36/cit36
ref18/cit18
ref11/cit11
ref25/cit25
ref29/cit29
ref32/cit32
ref39/cit39
ref14/cit14
ref5/cit5
ref43/cit43
ref28/cit28
ref40/cit40
ref12/cit12
ref15/cit15
ref41/cit41
ref22/cit22
ref33/cit33
ref4/cit4
ref30/cit30
ref47/cit47
ref1/cit1
ref44/cit44
ref7/cit7
References_xml – ident: ref10/cit10
  doi: 10.1017/S0954422416000032
– ident: ref35/cit35
  doi: 10.1021/acs.jcim.1c00380
– ident: ref49/cit49
  doi: 10.1002/jps.20075
– ident: ref25/cit25
– volume: 95
  start-page: 9
  year: 2018
  ident: ref26/cit26
  publication-title: Pharmacometrics
– ident: ref19/cit19
  doi: 10.1016/0006-291X(91)91647-U
– ident: ref38/cit38
  doi: 10.3390/molecules24152843
– ident: ref12/cit12
  doi: 10.1002/psc.870
– ident: ref2/cit2
  doi: 10.1016/j.bbrc.2018.06.118
– ident: ref41/cit41
  doi: 10.1016/j.coph.2013.08.004
– ident: ref32/cit32
  doi: 10.1021/pr0705035
– ident: ref39/cit39
  doi: 10.1002/mnfr.200700503
– ident: ref29/cit29
  doi: 10.1021/jf703640p
– ident: ref24/cit24
  doi: 10.1093/bbb/zbaa117
– ident: ref11/cit11
  doi: 10.1038/368563a0
– ident: ref47/cit47
  doi: 10.1016/j.ajps.2018.05.008
– ident: ref28/cit28
  doi: 10.1021/acs.jafc.7b02176
– ident: ref44/cit44
  doi: 10.1021/acs.jafc.3c04940
– volume: 45
  start-page: 1303
  issue: 8
  year: 2017
  ident: ref23/cit23
  publication-title: Jpn. Pharmacol Ther.
– ident: ref46/cit46
  doi: 10.3390/molecules28031151
– ident: ref16/cit16
  doi: 10.1016/0016-5085(89)90897-4
– ident: ref48/cit48
  doi: 10.1007/s11095-005-6156-9
– ident: ref30/cit30
  doi: 10.1016/0005-2744(74)90053-9
– ident: ref33/cit33
  doi: 10.1152/ajpgi.00136.2002
– ident: ref45/cit45
  doi: 10.1074/jbc.273.7.3861
– ident: ref20/cit20
  doi: 10.1179/1476830514Y.0000000122
– ident: ref4/cit4
  doi: 10.1016/j.peptides.2022.170843
– ident: ref42/cit42
  doi: 10.1016/j.foodchem.2015.05.121
– ident: ref14/cit14
  doi: 10.1083/jcb.102.6.2125
– ident: ref7/cit7
  doi: 10.1002/psc.371
– ident: ref15/cit15
  doi: 10.1074/jbc.270.47.28425
– ident: ref34/cit34
  doi: 10.1271/bbb.66.378
– ident: ref9/cit9
  doi: 10.1039/b301507f
– ident: ref21/cit21
  doi: 10.1080/09637486.2017.1324564
– ident: ref3/cit3
  doi: 10.3168/jds.S0022-0302(96)76585-2
– ident: ref27/cit27
  doi: 10.1021/acs.jafc.1c08191
– ident: ref18/cit18
  doi: 10.1002/mnfr.200900443
– ident: ref1/cit1
  doi: 10.3168/jds.S0022-0302(95)76745-5
– ident: ref36/cit36
  doi: 10.1021/jf405639w
– ident: ref40/cit40
  doi: 10.3390/pharmaceutics15102517
– ident: ref8/cit8
  doi: 10.3168/jds.S0022-0302(04)73453-0
– ident: ref22/cit22
  doi: 10.1080/09637486.2017.1365824
– ident: ref13/cit13
  doi: 10.1002/(SICI)1521-3803(19990601)43:3<154::AID-FOOD154>3.0.CO;2-A
– ident: ref31/cit31
  doi: 10.1002/0471140864.ps2103s25
– ident: ref6/cit6
  doi: 10.1096/fj.201900621R
– ident: ref43/cit43
  doi: 10.1016/j.jff.2017.06.001
– ident: ref17/cit17
  doi: 10.1042/bj2840595
– ident: ref5/cit5
  doi: 10.1016/j.neurobiolaging.2018.07.016
– ident: ref37/cit37
  doi: 10.1021/acs.jafc.5b01824
SSID ssj0008570
ssib000630454
ssib017385285
ssib045322535
ssib000983874
ssib045322530
ssib006542241
Score 2.4668384
Snippet Lactononadecapeptide (LNDP; NIP­PLT­QTP­VVV­PPF­LQ­PE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive...
Lactononadecapeptide (LNDP; NIPPLTQTPVVVPPFLQPE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function....
Lactononadecapeptide (LNDP; NIPPLTQTPVVVPPFLQPE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function....
SourceID pubmedcentral
proquest
pubmed
crossref
nii
acs
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 12719
SubjectTerms Biological Transport
Caco-2 Cells
Caseins - chemistry
Caseins - genetics
Caseins - metabolism
cognition
Enzyme Stability
Food and Beverage Chemistry/Biochemistry
food chemistry
human cell lines
Humans
intestinal mucosa
Intestinal Mucosa - metabolism
lipids
Peptide Transporter 1 - genetics
Peptide Transporter 1 - metabolism
peptide transporters
peptides
Peptides - chemistry
Peptides - metabolism
permeability
Title Investigating the Transepithelial Transport and Enzymatic Stability of Lactononadecapeptide (NIP­PLT­QTP­VVV­PPF­LQ­PE), a 19-Amino Acid Casein-Derived Peptide in Caco‑2 Cells
URI http://dx.doi.org/10.1021/acs.jafc.4c00974
https://cir.nii.ac.jp/crid/1873399491341085952
https://www.ncbi.nlm.nih.gov/pubmed/38789103
https://www.proquest.com/docview/3060373180
https://www.proquest.com/docview/3153613824
https://pubmed.ncbi.nlm.nih.gov/PMC11157532
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjZ3dbtMwFMctNm7ggu-PAkNGAolJpIudxHEuq9JqoDJ1oqt2F_krI1DcaWmRtitegQfpNfd9FJ6EYzcr65iq3VRp4ziNfXzO3_LJzwi9Br8oMx6ZQHKjg5hFNBBZzAJqMpWwKGbM0_Y_7bHdg_jjYXL4D5NzeQWfkh2hquZXUahmrNxLB_EGukkZT91Eq9X-vPS6DtS-SOcgAQdRUC9JXlWDC0SqWglEG7Ysr9KYl1MlL8Se7t3FJkaVRxa6lJNvzelENtXZ_0DHazzWPXSnlqC4tbCZ--iGsQ_Q7dbRSY3hMA_R7wv4DXuEQSRiH9TMsXuFYwQ2i5dUdCysxh17durhrxjUq8-3PcXjAvfcbj4WxL42LtEK3JM2-O3eh_581u8N5rP9ARwNh0P42u_OZ719OOhsv8MCkyxofS_tGLdUqXEbYm1pg_cwXH4Yjft1TaWFM2r85-cvittmNKoeoYNuZ9DeDeotHgIBM6dJkERUKSoLKUOdMJnyTIU00zqVmQItxKk0zBAjhdIx13GchJpwKUBzFA6Mz6PHaBOewjxFmAoppYiILhgFr6RlkabcpDLVnCSSsgZ6A22e10O0yv3qOyW5_xE6Iq87ooF2zu0iVzUn3W3XMVpzxfbyiuMFI2RN2S0wNajYfRKeRiAQY5f9QDxpjjbQq3MjzGGgu9UbYc14WuUwtwujFFxwuKYMxC_mqJJwnycLw13-o4hD65IwaiC-YtLLAg40vnrGll88cJw4IhN01bNrNuFzdIuC9vMZdckLtDk5mZot0G4T-dIP2r_lykNB
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLa28QA8cL8UGBgJJCaRLnYSx3msSqsOuqqDrtpbFF8yAiWdlhZpe-Iv8EP6zHt_Cr-EYzcN6zRV8BI5tuP4cnzOZ_n4M0KvQC-KiHvaEVwrx2cedZLIZw7VkQyY5zNm2fb3e6xz6L8_Co42EFmehYFKFFBSYTfx_7ILkF0T9yVJZd2X5uyBv4muARahZr3VaH6qlK_ha194dRCHAzYodyavKsHYI1ms2KPNPMuugpqXPSYvmKD2bfSxqrz1PPlan05EXZ5f4nX8r9bdQbdKQIobCwm6izZ0fg_dbByflqQc-j76dYGMIz_GABmxNXH6xBzoGIEE44ojHSe5wq38_MxSwWLAstb79gyPU9w1d_vkAP2VNm5XoKyUxm96e_35rN8dzGcHAwgNh0N47bfns-4BBFo7b3GCSeQ0vmX5GDdkpnATLG-WO-9g8nzXCvfLkrIcUuT494-fFDf1aFQ8QIft1qDZccoLH5wE1lETJ_ColFSkQrgqYCLkkXRppFQoIgnIiFOhmSZaJFL5XPl-4CrCRQIIJDU0-dx7iLagFfoxwjQRQiQeUSmjoKOUSMOQ61CEipNAUFZDr6HP43LCFrHdi6cktpEwEHE5EDW0uxSPWJas6ebyjtGaL3aqL04WjCFr8m6DxEHB5kl46AFc9I0vBLG8c7SGXi5lMYZpb_ZyklyPp0UMKz3XC0Ehu2vygDVjhmMS_vNoIb9VjTwOvUtcr4b4imRXGQzt-GpKnn229OPE8DPBUD35xy58ga53BvvduLvX-_AU3aCACq2vXfAMbU1Op3obUN1EPLfz-A_z-Uui
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bbtMwGLa2ISG44HwoMDASSEwiXewkjnNZda02KFUnump3UXzIllHSammRtitegQfpNfd9FJ6E324ardNUwU2Ug-PE9n_4rP_3Z4TegV0UEfe0I7hWjs886iSRzxyqIxkwz2fMsu1_6bL9I__TcXC8gYLlWhj4iQJqKmwQ32j1WKUlwwDZNffPklTWfWnWH_ib6JaJ2pk5V6P5tTLAhrN9kdlBHA74oIxO3lSD8UmyWPFJm3mW3QQ3r2dNXnFD7ftoUDXAZp98q08noi4vr3E7_ncLH6B7JTDFjYUkPUQbOn-E7jZOzktyDv0Y_b5CypGfYICO2Lo6PTYLO4YgybjiSsdJrnArv7ywlLAYMK3Nwr3AoxR3zB4_OUwBlDbpV2C0lMYfuge9-azX6c9nh304GwwGcNlrz2edQzhp7XzECSaR0_ie5SPckJnCTfDAWe7sgRL90Ar3ypqyHJ7I0Z-fvyhu6uGweIKO2q1-c98pN35wEphPTZzAo1JSkQrhqoCJkEfSpZFSoYgkICROhWaaaJFI5XPl-4GrCBcJIJHU0OVz7ynaglbo5wjTRAiReESljIKtUiINQ65DESpOAkFZDb2HPo9LxS1iG5OnJLY3YSDiciBqaHcpIrEs2dPNJh7DNW_sVG-MF8wha8pug9RBxeZIeOgBbPRNTgSx_HO0ht4u5TEG9TcxnSTXo2kRw4zP9UIwzO6aMuDVmOGahO88W8hw9Uceh94lrldDfEW6qwKGfnz1SZ6dWhpyYniaYKhe_GMXvkG3e3vtuHPQ_fwS3aEADm3KXfAKbU3Op3obwN1EvLaq_BdPr04l
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Investigating+the+Transepithelial+Transport+and+Enzymatic+Stability+of+Lactononadecapeptide+%28NIP%C2%ADPLT%C2%ADQTP%C2%ADVVV%C2%ADPPF%C2%ADLQ%C2%ADPE%29%2C+a+19-Amino+Acid+Casein-Derived+Peptide+in+Caco%E2%80%912+Cells&rft.jtitle=Journal+of+agricultural+and+food+chemistry&rft.au=Nakatani%2C+Eriko&rft.au=Sasai%2C+Masaki&rft.au=Miyazaki%2C+Hidetoshi&rft.au=Tanaka%2C+Shimako&rft.date=2024-06-05&rft.issn=1520-5118&rft.volume=72&rft.issue=22+p.12719-12724&rft.spage=12719&rft.epage=12724&rft_id=info:doi/10.1021%2Facs.jafc.4c00974&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-8561&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-8561&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-8561&client=summon